Contribution of genotoxic anticancer treatments to the development of multiple primary tumours in the context of germline TP53 mutations. - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Journal of Cancer Année : 2018

Contribution of genotoxic anticancer treatments to the development of multiple primary tumours in the context of germline TP53 mutations.

Fichier non déposé

Dates et versions

hal-02355640 , version 1 (08-11-2019)

Identifiants

Citer

Edwige Kasper, Emilie Angot, Elodie Colasse, Lionel Nicol, Jean-Christophe Sabourin, et al.. Contribution of genotoxic anticancer treatments to the development of multiple primary tumours in the context of germline TP53 mutations.. European Journal of Cancer, 2018, ⟨10.1016/j.ejca.2018.06.011⟩. ⟨hal-02355640⟩
26 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More